Amgen Inc. Q4 Profit Decreases, but beats estimates

Amgen Inc. (AMGN) released earnings for fourth quarter that decreased from last year but beat the Street estimates.

The company's bottom line came in at $767 million, or $1.42 per share. This compares with $1.62 billion, or $3.00 per share, in last year's fourth quarter.

Excluding items, Amgen Inc. reported adjusted earnings of $2.54 billion or $4.71 per share for the period.

Analysts on average had expected the company to earn $4.60 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 19.9% to $8.20 billion from $6.84 billion last year.

Amgen Inc. earnings at a glance (GAAP) :

-Earnings (Q4): $767 Mln. vs. $1.62 Bln. last year.
-EPS (Q4): $1.42 vs. $3.00 last year.
-Analyst Estimates: $4.60
-Revenue (Q4): $8.20 Bln vs. $6.84 Bln last year.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com